Lloyd Mackenzie
President chez Symvivo Corp.
Provenance du réseau au premier degré de Lloyd Mackenzie
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
21
| Extinct | Pharmaceuticals: Major | 21 |
| Public Company | Pharmaceuticals: Major | 5 | |
Adapsyn Bioscience, Inc.
 Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada.
4
| Holding Company | Biotechnology | 4 |
Symvivo Corp.
 Symvivo Corp. BiotechnologyHealth Technology Symvivo Corp. is a Canadian clinical-stage biotechnology company that specializes in advancing therapeutics in the area of oral DNA vaccines, oncology, immunology, and gene replacement. The private company's Bactrl platform technology delivers plasmid DNA, both orally and through IV application, that enables a patient's own cells to produce therapeutic proteins. Symvivo is headquartered in Burnaby, Canada. The company was founded by Alexander Graves, who has been the CEO since incorporation.
2
| Private Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lloyd Mackenzie via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Director of Finance/CFO Director of Finance/CFO | |
| SERNOVA CORP. | Biotechnology | Chairman | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Chairman | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer | |
| GLOBAL GAMING TECHNOLOGIES CORP. | Financial Conglomerates | President | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder Human Resources Officer | |
| Queen's University | College/University | Graduate Degree | |
| Indiana University | College/University | Graduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Masters Business Admin | |
| Simon Fraser University | College/University | Undergraduate Degree Undergraduate Degree | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Redlen Technologies, Inc.
 Redlen Technologies, Inc. SemiconductorsElectronic Technology Redlen Technologies, Inc. engages in the manufacture of resolution Cadmium Zinc Telluride semiconductor radiation detectors. It enables performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. The company was founded in November 1999 and is headquartered in Saanichton, Canada. | Semiconductors | Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Human Resources Officer | |
| Pacific Biopartners | Corporate Officer/Principal | ||
| PROOF Centre of Excellence | Chairman | ||
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Providence Health Care (Vancouver) | Director/Board Member | ||
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| DELIVRA HEALTH BRANDS INC. | Agricultural Commodities/Milling | Chairman | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ponderosa Capital, Inc.
 Ponderosa Capital, Inc. Investment ManagersFinance Ponderosa Capital, Inc. is a private company based in Vancouver, Canada. The company provides webnames.ca Canadian domain name registration and domain management services. Another domain registered by the company is currently under development and hosted by webnames.ca. Customers are advised to check back later for updates on the website. Frank A. Holler has been the CEO of the company since 2003. | Investment Managers | Chief Executive Officer | |
| British Columbia Biotechnology Association | Director/Board Member | ||
Nimbus Synergies, Inc.
 Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | Investment Managers | Founder |
Statistiques
Internationale
| Canada | 30 |
| Etats-Unis | 17 |
| Royaume-Uni | 4 |
| Suède | 2 |
Sectorielle
| Health Technology | 24 |
| Finance | 8 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 126 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 43 |
| Chief Tech/Sci/R&D Officer | 33 |
| Undergraduate Degree | 22 |
Relations les plus connectées
| Insiders | |
|---|---|
| Elaine Jones | 37 |
| Frank Holler | 29 |
| Sean Nolan | 18 |
| Gary Bridger | 16 |
| Richard Levy | 16 |
| Kelvin Neu | 15 |
| Todd Simpson | 14 |
| Paul Brennan | 14 |
| Daniel J. Levitt | 13 |
| Abbey Jenkins | 12 |
| Eric Sievers | 12 |
| Robert E. Pelzer | 12 |
| David Mitchell | 12 |
| Robert Gerhard Pilz | 11 |
| Christopher O’Donnell | 11 |
- Bourse
- Insiders
- Lloyd Mackenzie
- Connexions Sociétés
